CIK: 1214938 - Address: C/o Vericel Corporation, 64 Sidney Street, Cambridge, MA 02139
42 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret11221-0133-21
S%wins50556464486357

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
11/15/24 16:05
11/13/24
VCELVericel CorpMIHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMADS.d-38955.540-7-3712D
8/9/24 16:05
8/7/24
VCELVericel CorpMIHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMADS.d-32245.940-7-3712D
9/24/21 19:36
9/23/21
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.dm-4,008160.330-25-7011D
1/6/21 19:03
1/4/21
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.m-589123.240-5-456D
12/15/20 18:24
12/14/20
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-5,535130.140-43-7911D
12/11/20 18:08
12/9/20
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.dm-934125.020-7-4011D
4/10/20 17:29
4/8/20
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.dm-4,66486.370-54-8311D
1/3/20 21:41
1/2/20
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S-29352.500-6-545D
12/17/19 18:39
12/13/19
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S-59650.280-12-5310D
9/10/19 20:22
9/10/19
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S-36245.300-8-2622D
4/11/19 16:58
4/9/19
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S-53544.620-12-2830D
4/4/19 18:07
4/2/19
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S-3148.020-1-242D
1/4/19 18:34
1/2/19
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S-24442.800-6-1338D
8/31/18 19:00
8/30/18
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-67554.000-13-2244D
7/3/18 14:32
6/29/18
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-1,20048.000-25-3644D
4/4/18 16:38
4/3/18
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S-15438.450-4-844D
1/4/18 19:03
1/2/18
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.dm-81542.890-19-3143D
9/14/17 17:02
9/12/17
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S-61538.410-16-2549D
7/7/17 16:55
7/5/17
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-1,10132.000-34-3565D
1/6/17 17:12
1/4/17
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S-4727.4512-2-271D-29-27-20-25-27-6-1610-8-1
7/6/16 17:45
7/1/16
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-87734.6613-25-3158D-28-2710-4-8-6-6-22-13-27
5/25/16 16:29
5/23/16
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-86034.0012-25-2768D123-1231925175-1-31-119
10/9/15 17:04
10/7/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-17124.3810-7-880D5-20-29-19-15-320-1-2164432639
9/10/15 16:55
9/8/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-19630.166-7-1440D26-24-110151141-2531-200
8/12/15 17:56
8/10/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-18528.534-7-1440D-5-25-11-10-12-131371235-110
7/9/15 16:59
7/7/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-20829.706-7-1735D-1-25-18-17-7-10-419-7-202514
6/9/15 17:18
6/8/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-21132.495-7-1830D6-12-2030-2110-7-63615
5/13/15 16:01
5/11/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-20731.806-7-1830D-26-15-16-5129030-1121-7
4/8/15 17:12
4/7/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-24434.8810-7-2225D-510-11-13-17-5-8-3-3-20-16-31-9
3/10/15 16:08
3/9/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-26240.258-7-2125D-206311070000-14-20-29-32
2/11/15 16:02
2/9/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-23836.649-7-2125D-172625-3-4-50-3-28-19-29-36
1/13/15 16:27
1/12/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-8140.6613-2-725D-134438655313-3-16-21-13
1/9/15 17:47
1/7/15
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-19739.4615-5-1725D0363615467-1-1-11-17-27-16
12/9/14 17:27
12/8/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-44044.0211-10-5010D642773232911190-13-5-6-28-4
11/14/14 16:02
11/12/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-33133.148-10-5010D81101814329-121314-26
10/9/14 16:59
10/7/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-29329.256-10-1000D30-2007232-320174017-16
9/10/14 20:05
9/8/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.dm-24524.484-10-1000D-49-27-15-14-10-51-219696222
8/15/14 16:14
8/14/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-29829.785-10-1000D-32-5-10710-1-12-1413275
7/9/14 17:53
7/7/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-31731.7212-10-1000D-29-20-6-15-17-151-10-3-327-5
6/11/14 16:39
6/9/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-31631.6511-10-1000D30-3006141154-7-2430-4
5/21/14 18:51
5/19/14
XLRNAcceleron Pharma IncDEHealthBioPrdBiological Products, (No DiagMcLaughlin Kevin FMAOSVP,CFO,S.d-31531.5112-10-1000D61-28-12-8016515-31212
12/3/03 18:29
12/2/03
PRCSPraecis Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMcLaughlin Kevin FMAOSVP,CFOS.d-2627.490-35-14219D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact